Researcher.Life Logo

Clinical and Experimental Rheumatology : Impact Factor & More

eISSN: 1593-098XpISSN: 0392-856X

Key Metrics

CiteScore
6.1
H-Index
104
Impact Factor
< 5
SJR
Q2Immunology
SNIP
1.56
Recommended pre-submission checks
Powered by Paperpal by Editage

Clinical and Experimental Rheumatology Journal Specifications

Overview
Publisher CLINICAL & EXPER RHEUMATOLOGY
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1983
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Clinical and Experimental Rheumatology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Clinical and Experimental Rheumatology

Upadacitinib in psoriatic arthritis with prior TNF-inhibitor failure: a 56-week real-world study.
  • 13 Nov 2025
  • Clinical and experimental rheumatology
Social support and depression status are risk factors of frailty in systemic lupus erythematosus patients: multicentre retrospective analysis using the Systemic Lupus Erythematosus International Collaborating Clinics-Frailty Index.
  • 11 Nov 2025
  • Clinical and experimental rheumatology
Clinical predictors of remission in systemic juvenile idiopathic arthritis/Still's disease: insight from real-life data and the potential relevance of the 'window of opportunity'.
  • 23 Oct 2025
  • Clinical and experimental rheumatology
Predictors of post-operative cardiovascular complications for Behçet's disease with pre-operative immunosuppressive therapy.
  • 23 Oct 2025
  • Clinical and experimental rheumatology
The impact of first-line tumour necrosis factor inhibitor treatment on anti-infective use in patients with axial spondyloarthritis: a nationwide retrospective cohort study.
  • 2 Oct 2025
  • Clinical and experimental rheumatology
Serum NLRC3 levels in systemic lupus erythematosus: correlation with clinical characteristics.
  • 2 Oct 2025
  • Clinical and experimental rheumatology
Upadacitinib in psoriatic arthritis with prior TNF-inhibitor failure: a 56-week real-world study.
  • 13 Nov 2025
  • Clinical and experimental rheumatology
Social support and depression status are risk factors of frailty in systemic lupus erythematosus patients: multicentre retrospective analysis using the Systemic Lupus Erythematosus International Collaborating Clinics-Frailty Index.
  • 11 Nov 2025
  • Clinical and experimental rheumatology
Clinical predictors of remission in systemic juvenile idiopathic arthritis/Still's disease: insight from real-life data and the potential relevance of the 'window of opportunity'.
  • 23 Oct 2025
  • Clinical and experimental rheumatology
Predictors of post-operative cardiovascular complications for Behçet's disease with pre-operative immunosuppressive therapy.
  • 23 Oct 2025
  • Clinical and experimental rheumatology
The impact of first-line tumour necrosis factor inhibitor treatment on anti-infective use in patients with axial spondyloarthritis: a nationwide retrospective cohort study.
  • 2 Oct 2025
  • Clinical and experimental rheumatology
Serum NLRC3 levels in systemic lupus erythematosus: correlation with clinical characteristics.
  • 2 Oct 2025
  • Clinical and experimental rheumatology

FAQs on Clinical and Experimental Rheumatology